Bethesda, Maryland USA
Main Conference: 10 - 11 October
2018 US Interchange
Educational Courses: 8, 9, 12 October
Learn CDISC from CDISC
CDISC Standards Required for Regulatory Submissions to FDA (U.S.) and PMDA (Japan)
Are You Ready?
Unlocking Cures is our life’s work.

At CDISC, we enable clinical research to work smarter by allowing data to speak the same language. As a global, nonprofit standards development organization with a worldwide team of staff and volunteer experts across the medical community, our data standards streamline clinical research and enable connections to healthcare, empowering the valuable information offered by patients participating in research studies around the world.

Our quest for 100% adoption of CDISC standards will pave the way for the sharing and comparing of data, leading to transformative advancements in research and patient care.

Global Regulatory Requirements

CDISC Standards are now required for regulatory submissions to FDA (U.S.) and PMDA (Japan).      


CDISC relies on the subject matter expertise of thousands of volunteers to create vendor-neutral, platform-independent data standards that enable information system interoperability to improve medical research. 


Generate awareness to the important work CDISC is doing by sponsoring a CDISC fundraiser or event.

Job Opportunities

Contribute your talents and abilities by joining the CDISC Team or find a position that needs CDISC expertise at one our Member organizations.


Allocate your donation to a disease that has affected a loved one. 100% of your contribution will create data standards that improve clinical research processes to develop new treatments, find breakthroughs and unlock cures.

Save Time and Resources

Implementing CDISC standards can save approximately 60% in time and resources to conduct clinical research. And implementing CDISC standards from the start can save 70-90% of study start-up time.

"CDISC has renewed my hope and my dream of making clinical trials faster and more cost-effective by harnessing the data in the EHR."

Kelley Meyer, MS
NRG Oncology Statistics and Data Management Center, University of Pittsburgh

Smarter Research to Unlock Cures

“Having good industry standards for our clinical data is so important because it creates order among the relative chaos of our clinical trial data. When we start to really do that, we can focus our energies on the really innovative and differentiating aspects of the clinical trials we run and stop reinventing the wheel.”

Jonathan Chainey
Global Head, Data Standards, Roche

75% of study data submitted within all NDA submissions are in standardized SDTM format**

**Source: Office of Business Informatics, CDER - One or more explicitly stated SDTM studies (or study data structure that resembled SDTM).

"It is our honor to join the CDISC family. We studied, used, and benefited from CDISC standards, and it is our responsibility to contribute to CDISC."

CDISC Member